Project Grant R01MD021111
Award Date 9/13/25
Completion Date 6/30/30
Dollars Obligated $898K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
- The U.S. Department of Health and Human Services' HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939) awarded a $1,702,777.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on July 1, 2025. The grant supports UCSF's comprehensive efforts to prevent, diagnose, and address HIV transmission through targeted community-based interventions, with a focus on developing and implementing effective HIV prevention strategies for high-risk...
- The National Heart Lung and Blood Institute (NHLBI) awarded a $3,264,423 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Regents of the University of California, San Francisco (UCSF) to study the mechanisms underlying the increased risk of sudden cardiac death in people with HIV. The research aims to characterize the myocardial tissue effects of treated HIV, including immune activation, cardiac ion channel dysregulation, and region-specific arrhythmic...
- The National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), awarded a $688,525 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of California, San Diego (UCSD). The grant, titled "Blood Pressure Control Advancing Refugee Health Equity (BPCARE): An RCT of Adherence", aims to develop and test a behavioral intervention to improve antihypertensive medication adherence and blood pressure...
- The University of California, San Diego (UCSD) was awarded a $2,911,005 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct a retrospective study evaluating the impact of public health activities related to the HIV care continuum in New York City. The project, titled "CHROME: Continuum of HIV Response through Observational Molecular Epidemiology", aims to determine if individuals without...
- This $2,979,575 Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) will fund the "FIM+DASH: A Randomized Food Is Medicine Trial to Promote Healthy Eating and Blood Pressure Control in Hypertensive Black Women with Obesity" research project. The 4-year study, which begins on September 14, 2025, will be conducted by the University of Illinois in Chicago. The project aims to evaluate the...
- The University of California, San Francisco (UCSF) was awarded a $675,962 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of the grant is to characterize the interaction between human and vector behaviors in order to enhance the impact of malaria control interventions in Uganda. The project will integrate rigorous human behavioral and entomological monitoring data to elucidate...
- The University of New Mexico Health Sciences Center received a $117,720 Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) to study disparities in hospital-based care and outcomes for out-of-hospital cardiac arrest (OHCA) patients. The project aims to 1) identify interhospital differences in OHCA care and outcomes, 2) analyze variations in OHCA care modalities and their impact on outcomes using...
- The University of California, San Francisco (UCSF) was awarded a $206,180 Project Grant from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to investigate the complex intersection of HIV, methamphetamine use, and immune dysfunction. The 5-year grant, awarded on Sep 1, 2025, will support a comprehensive, data-driven research approach to examine how methamphetamine exposure influences HIV reservoir transcription and host immune responses, with the...
- This federal Project Grant award of $198,549.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) is supporting research to determine the contribution of HIV and menopausal phase to cardiovascular disease (CVD) risk parameters and subclinical atherosclerosis in women with HIV. The study aims to (1) assess the association of HIV and menopausal phase with CVD risk factors, (2) evaluate the relationship between HIV, menopausal phase, immune...
- This $223,438 federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to assess the incidence of hypertension in antiretroviral therapy (ART)-naive people with HIV after initiating bictegravir versus dolutegravir-based ART, determine if weight gain is associated with incident hypertension, and evaluate HIV and non-HIV risk factors for incident hypertension. The award was granted to the University of Alabama at...